These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21123112)

  • 1. Blood-pressure drugs and cancer: much ado about nothing?
    Lindholm LH; Carlberg B
    Lancet Oncol; 2011 Jan; 12(1):6-8. PubMed ID: 21123112
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
    Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
    Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive therapy].
    Schmieder RE; Veelken R
    MMW Fortschr Med; 2009 Apr; 151(14):95-8; quiz 99. PubMed ID: 19504848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is one antihypertensive agent as good as another?].
    Trenkwalder P
    MMW Fortschr Med; 2002 Nov; 144(45):41-2. PubMed ID: 12534060
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
    Dominiak P
    MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of the international literature on isradipine in hypertension (Lomir/Dynacirc).
    Soland FX
    Cor Vasa; 1990; 32(2 Suppl 1):61-72. PubMed ID: 2143461
    [No Abstract]   [Full Text] [Related]  

  • 7. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefits and risks of combination therapy in hypertension.
    Node K
    Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
    [No Abstract]   [Full Text] [Related]  

  • 9. Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.
    Med Lett Drugs Ther; 2008 Aug; 50(1293):65-6. PubMed ID: 18719523
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.
    Waeber B; Mourad JJ
    Am J Hypertens; 2006 Sep; 19(9):985-6. PubMed ID: 16942945
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antihypertensive therapy: campaign of the giants].
    Füessl HS
    MMW Fortschr Med; 2005 Dec; 147(51-52):28. PubMed ID: 16402700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alpha-blockers in therapy of arterial hypertension. No longer the drug of first choice].
    Faulhaber HD
    MMW Fortschr Med; 2001 May; 143(22):30-2. PubMed ID: 11460395
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?].
    Dechend R; Derer W; Müller DN
    MMW Fortschr Med; 2009 Nov; 151(45):46-7. PubMed ID: 19960726
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of angiotensin-II-antagonists in hypertension].
    Birkenhäger WH; de Leeuw PW
    Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1397-402. PubMed ID: 10923148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trials.
    Zou Z; Xu FY; Wang L; An MM; Zhang H; Shi XY
    J Hum Hypertens; 2011 Mar; 25(3):203-10. PubMed ID: 20535140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A
    Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes from treatment. Clinical applications from recent trials.
    Howes LG
    Aust Fam Physician; 1999 Jul; 28(7):707-10. PubMed ID: 10431429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern hypertension treatment. More than effective blood pressure reduction].
    MMW Fortschr Med; 2012 Nov; 154(20):78-9. PubMed ID: 23234126
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of combination therapy in treatment of hypertension].
    Kreutz R
    Krankenpfl J; 2005; 43(7-10):255. PubMed ID: 16515324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.